Rights and permissions
About this article
Cite this article
Home IV antibacterial service for CF reduces costs by 45%. Pharmacoecon. Outcomes News 42, 12 (1995). https://doi.org/10.1007/BF03309923
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03309923